Justify The Fundamental Reasons Marketers Should Close

Justify The Fundamental Reasons That Marketers Should Closely Monitor

In the dynamic and competitive landscape of modern marketing, especially within the healthcare industry, the importance of closely monitoring rivals cannot be overstated. Marketing professionals need to maintain a vigilant awareness of competitor actions, market trends, and environmental shifts to make informed decisions, remain competitive, and proactively address emerging challenges and opportunities. This paper explores the fundamental reasons why marketers should engage in diligent competitor monitoring, provides an illustrative example of successful close monitoring, evaluates the utility of Lehmann and Winer’s Level of Competition Model in healthcare, and offers specific instances of its application within a healthcare organization.

Fundamental Reasons for Close Monitoring of Rivals by Marketers

The primary justification for rigorous competitor monitoring lies in the necessity to anticipate and respond to market movements swiftly. In a rapidly evolving sector such as healthcare, where technological innovations, regulatory changes, and shifting patient preferences continually reshape the environment, understanding competitor strategies enables organizations to identify gaps and emerging trends. This knowledge facilitates strategic positioning, product development, and marketing communication that align with or proactively shape market expectations.

Furthermore, close monitoring allows marketers to detect potential threats early. For example, the introduction of a disruptive new service or technological innovation by a rival can significantly impact a healthcare provider’s market share. By observing such moves early, an organization can develop countermeasures or innovate further to sustain competitiveness.

Additionally, competitor analysis informs market segmentation and targeting strategies by revealing where competitors are investing and which customer segments they are prioritizing. Such insights enable more precise positioning and resource allocation.

Another reason pertains to the necessity for compliance and ethical considerations. Monitoring competitors ensures that a healthcare organization adheres to industry standards and avoids unethical practices that could result in legal penalties or reputational damage.

Lastly, in healthcare, reputation management is crucial; understanding how rivals engage with patients and stakeholders can inform a provider’s communication strategies, ensuring that they maintain a positive public image and trustworthiness.

Example of Successful Close Monitoring

A notable example of effective competitor monitoring comes from the healthcare giant, Kaiser Permanente. When a regional competitor began expanding its telehealth services rapidly, Kaiser Permanente's leadership closely monitored the competitor’s digital offerings, patient feedback, and marketing campaigns. This vigilance enabled Kaiser to swiftly enhance its telehealth platform, introduce new virtual care options, and update marketing strategies to retain its patient base. The proactive response not only mitigated potential patient attrition but also positioned Kaiser as a leader in telehealth, illustrating the importance of real-time monitoring for strategic advantage.

Evaluation of Lehmann and Winer’s Level of Competition Model in Healthcare

Lehmann and Winer’s Level of Competition Model provides a valuable framework for assessing the competitive landscape by categorizing competition into various levels, including monopoly, oligopoly, monopolistic competition, and perfect competition. This model assists health care organizations in accurately identifying the degree of market rivalry and understanding how external forces influence their strategic options. Its strength lies in helping managers determine the intensity of competition and tailor their marketing strategies accordingly.

Within the healthcare industry, this model offers clarity in navigating complex market dynamics where multiple players, such as hospitals, insurance companies, pharmaceutical firms, and outpatient clinics, interact at varying levels of competition. Recognizing whether a market is highly concentrated or fragmented enables tailored approaches to pricing, service differentiation, and partnership development.

Examples of Application within a Healthcare Organization

The first application can be observed in hospital mergers and acquisitions. When a hospital system notices increased competition from larger health networks, applying Lehmann and Winer’s model helps evaluate whether the market remains monopolistically competitive or shifts towards oligopoly or monopoly. This assessment informs strategic decisions such as expanding specialty services or forming alliances to enhance market power.

Secondly, within outpatient clinics or primary care practices, understanding the level of competition influences marketing and service innovation. For instance, if a clinic recognizes it operates in a highly fragmented competitive environment, it might focus on differentiating through specialized services or superior patient experience, guided by insights derived from the model.

Conclusion

In conclusion, the value of close competitor monitoring in healthcare marketing is undeniable. It enables organizations to stay ahead of industry changes, respond swiftly to threats, and capitalize on emerging opportunities. Lehmann and Winer’s Level of Competition Model offers a strategic tool for accurately understanding the competitive landscape, thereby enhancing decision-making processes. When applied thoughtfully, it provides healthcare providers with a competitive edge, supporting sustainable growth and improved patient outcomes through strategic adaptation and innovation.

References

• Fill, C. (2011). Marketing Communications: Evidence-Based Approach. Pearson Education.
• Lehmann, D. R., & Winer, R. S. (2005). Analysis for Marketing Planning. McGraw-Hill.
• Kumar, V., & Reinartz, W. (2016). Customer Relationship Management: Concept, Strategy, and Tools. Springer.
• Himmelstein, D. U., & Woolhandler, S. (2016). The current and projected taxpayer burdens of health costs in the USA. American Journal of Preventive Medicine, 50(6), 842-846.
• Porter, M. E. (2008). The five competitive forces that shape strategy. Harvard Business Review, 86(1), 78–93.
• Smith, T. (2019). Competitive strategies in healthcare: An overview of recent developments. Healthcare Management Review, 44(2), 142-152.
• Dittrich, A., & von Peter, P. (2020). Strategic health care marketing. Journal of Health Management, 22(3), 340-355.
• Chen, Y., & Mick, S. (2014). Understanding market competition in healthcare. Health Policy and Technology, 3(2), 91-97.
• Yarbrough, A., & Yarbrough, B. (2010). The Rise of Telehealth in Modern Medicine. Medical Economics, 87(13), 41-44.
• Krishnan, R., & Hartline, M. (2017). Managing Competition in Healthcare Markets. Journal of Healthcare Marketing, 5(1), 15-24.